Stay updated on Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.

Latest updates to the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry v3.5.3 was added to the Record History, and the previous revision entry v3.5.2 was removed, reflecting an update to the page's version history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision v3.5.2 was added to the record history and revision v3.5.0 was removed.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded revision v3.5.0 and deleted revision v3.4.3 from the history.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry v3.4.3 is added to the record history, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.4.2 added and a prior site-wide notice about funding (v3.4.1) removed. These updates are administrative and do not affect the study record content or essential navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check99 days agoChange DetectedAdded a site-wide government funding notice and updated operating-status information (cc.nih.gov and opm.gov). The history now shows Revision: v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.